홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

Phentermine Hydrochloride

HCID 70969
새 반응
인쇄
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
1197-21-3
표준 SMILES
CC(C)(N)Cc1ccccc1.Cl
InChIKey
NCAIGTHBQTXTLR-UHFFFAOYSA-N
분자식
C10H16ClN
평균 분자량
185.69 g/mol
단동위원소 질량
185.0971272

개요

Phentermine Hydrochloride is the hydrochloride salt form of phentermine, a sympathomimetic amine with central nervous system (CNS) stimulant and appetite depressant properties. Phentermine hydrochloride stimulates the release of norepinephrine and dopamine from nerve endings and blocks the reuptake of these monoamines at the neuronal junctions, resulting in CNS stimulation and metabolic effects, including appetite-suppression, decreased gastric acid secretion and increased blood pressure.

이름 및 식별자

우선 이름
Phentermine Hydrochloride
IUPAC
2-methyl-1-phenylpropan-2-amine;hydrochloride

이름 및 동의어

Phentermine hydrochloride1197-21-3Phentermine HClFastinOby-TrimToraOna-MastObestin-30SuprenzaWilpoZantrylLomaira
이름 더 보기
Phenyl-t-butylamine hydrochloridePhentermine hydrochloride civNSC-440901-Phenyl-2-methyl-2-aminopropane hydrochloride0K2I505OTVPhentermine hydrochloride [USP]Benzeneethanamine, alpha,alpha-dimethyl, hydrochloridePhentermine hydrochloride (USP)

데이터베이스 식별자

CAS
1197-21-3
PubChem CID
70969
DTXSID
DTXSID20152550
ChEMBL
CHEMBL1200912
UNII
0K2I505OTV
EC Number
214-821-9

물성

구조 계산 물성

극성 표면적
26 Ų
수소 결합 공여자 수
2
수소 결합 수용자 수
1
회전 가능 결합 수
2
무거운 원자 수
12
형식 전하
0
복잡도
112

실험 및 물리화학적 성질

Human Drugs · 3건

Breast Feeding; Lactation; Milk, Human; Anti-Obesity Agents

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 4건

Danger

H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]

P264, P270, P301+P316, P321, P330, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 79 reports by companies from 1 notifications to the ECHA C&L Inventory.

유해성 정보

Regulatory InformationBenzeneethanamine, .alpha.,.alpha.-dimethyl-, hydrochloride: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.
Other Safety InformationIMAP assessments - Benzeneethanamine, .alpha.,.alpha.-dimethyl-, hydrochloride: Environment tier I assessment
Hazard Classes and CategoriesAcute Tox. 3 (100%)

독성 정보

Treatment · 1건

Management of acute phentermine intoxication is largely symptomatic and includes lavage and sedation with a barbiturate. Acidification of the urine increases phentermine excretion. Intravenous phentolamine (REGITINE) has been suggested for possible acute, severe hypertension, if this complicates phentermine overdosage. (L1712)

Health Effects · 1건

Using large amounts of these drugs can result in a condition known as amphetamine psychosis -- which can result in auditory, visual and tactile hallucinations, intense paranoia, irrational thoughts and beliefs, delusions, and mental confusion. Using large amounts of these drugs can result in a condition known as amphetamine psychosis -- which can result in auditory, visual and tactile hallucinations, intense paranoia, irrational thoughts and beliefs, delusions, and mental confusion.

화학 및 산업

약리 정보

Metabolism/MetabolitesHepatic. Half Life: 16 to 31 hours
FDA Pharmacological Classification · 4건

PHENTERMINE HCL C-IV

Increased Sympathetic Activity [PE]; Appetite Suppression [PE]; Sympathomimetic Amine Anorectic [EPC]

PHENTERMINE HYDROCHLORIDE

Appetite Suppression [PE]; Sympathomimetic Amine Anorectic [EPC]; Increased Sympathetic Activity [PE]

MeSH Pharmacological Classification · 4건

A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here.

Agents that are used to suppress appetite.

Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters.

Drugs that act on adrenergic receptors or affect the life cycle of adrenergic transmitters. Included here are adrenergic agonists and antagonists and agents that affect the synthesis, storage, uptake, metabolism, or release of adrenergic transmitters.

용도 및 제조

UsesFor the treatment and management of obesity.

관련 반응

9건
반응 기록 만들기
HRID 329908 반응식
HRID 329908반응물로
HRID 1437130 반응식
HRID 1437130반응물로
HRID 1484012 반응식
HRID 1484012반응물로
HRID 1484013 반응식
HRID 1484013반응물로
HRID 1484014 반응식
HRID 1484014반응물로
HRID 1484015 반응식
HRID 1484015반응물로
HRID 1484016 반응식
HRID 1484016반응물로
HRID 1670799 반응식
HRID 1670799반응물로
이전1 / 2 페이지

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
Exposure RoutesPhentermine is rapidly absorbed after oral ingestion.
Toxicity Summary · 1건

Phentermine is an amphetamine that stimulates neurons to release or maintain high levels of a particular group of neurotransmitters known as catecholamines; these include dopamine and norepinephrine. High levels of these catecholamines tend to suppress hunger signals and appetite. The drug seems to inhibit reuptake of noradrenaline, dopamine, and seratonin through inhibition or reversal of the reuptake transporters. It may also inhibit MAO enzymes leaving more neurotransmitter available at the synapse.Phentermine (through catecholamine elevation) may also indirectly affect leptin levels in the brain. It is theorized that phentermine can raise levels of leptin which signal satiety. It is also theorized that increased levels of the catecholamines are partially responsible for halting another chemical messenger known as neuropeptide Y. This peptide initiates eating, decreases energy expenditure, and increases fat storage.

Signs and SymptomsSymptoms of overdose include delirium, mania, self-injury, marked hypertension, tachycardia, arrhythmia, hyperpyrexia, convulsion, coma, and circulatory collapse.
Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Effects During Pregnancy and Lactation◉ Summary of Use during Lactation
Toxicity DataLD50: 15 to 20 mg/kg (monkey).